Sarcoma trials in Singapore

5 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

• Phase 1Taking people
  Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors

  Where

  Singapore

  Age

  18 years and over

  People

  180 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT07261631
• Phase 1Taking people
  A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)

  Where

  Singapore

  Age

  18 years and over

  People

  405 worldwide

  Run by

  Hoffmann-La Roche

  See details and how to joinNCT06884618 · EU 2024-519622-20-00
• Phase 1/2Taking people
  A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

  Where

  Singapore

  Age

  Up to 25 years

  People

  75 worldwide

  Run by

  Turning Point Therapeutics, Inc.

  See details and how to joinNCT04094610 · EU 2023-506464-14-00
• Phase 1/2Taking people
  A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  Where

  Singapore

  Age

  12 years and over

  People

  500 worldwide

  Run by

  Turning Point Therapeutics, Inc.

  See details and how to joinNCT03093116 · EU 2024-512606-25-00
• No phaseTaking people
  Using QPOP to Predict Treatment for Sarcomas and Melanomas

  Where

  Singapore

  Age

  21 years to 99 years

  People

  100

  Run by

  National Cancer Centre, Singapore

  See details and how to joinNCT04986748